Competing interests
SD
BRILL
AL is a consultant for Alcon, Bausch & Lomb, Santen Pharmaceutical Co. Ltd., Keridon, Laboratoires Théa, URSA-pharma, Seqirus, SIFI, SOOFT-Fidia; SD is a consultant for Horus Pharma, Santen Pharmaceutical Co. Ltd., Alcon, Allergan, Bausch & Lomb, and Laboratoires Théa; PA is a consultant or has received financial support from Alcon Italia, Allergan, Bausch & Lomb, DMG Italia, Medivis, Novartis, Offhealth, Santen Italia, SIFI S.p.A, Fidia-Sooft, and Laboratoires Théa; MA is an employee of Santen SAS France; DI is an employee of Santen SAS France; JM has been a consultant for Brill Pharma, Santen Pharmaceutical Co. Ltd., Alcon, Bausch & Lomb, Sifi, Laboratoires Théa; JN has no financial disclosure to declare; DBG is a consultant for Novartis, Santen Pharmaceutical Co. Ltd., Alcon, Allergan, Bausch & Lomb, and Laboratoires Théa.